Assessing Henry Schein’s Valuation As Recent Share Price Momentum Draws Fresh Investor Attention

Simply Wall St.

Feb 09

AdvertisementWhy Henry Schein Is Back on Investors’ Radar Henry Schein (HSIC) has drawn fresh attention after a stretch of mixed share performance, with modest gains over the past month and past 3 ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2610709215"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2610709215\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2610709215?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice2-main-header/1585186857496","is_english":true,"pubTime":"2026-02-09 03:09","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2610709215","market":"nz","top_or_hot":-1,"title":"Assessing Henry Schein’s Valuation As Recent Share Price Momentum Draws Fresh Investor Attention","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementWhy Henry Schein Is Back on Investors’ Radar Henry Schein (HSIC) has drawn fresh attention after a stretch of mixed share performance, with modest gains over the past month and past 3 ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-hsic/henry-schein/news/assessing-henry-scheins-valuation-as-recent-share-price-mome\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Assessing Henry Schein’s Valuation As Recent Share Price Momentum Draws Fresh Investor Attention</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAssessing Henry Schein’s Valuation As Recent Share Price Momentum Draws Fresh Investor Attention\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-09 03:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nasdaq-hsic/henry-schein/news/assessing-henry-scheins-valuation-as-recent-share-price-mome><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementWhy Henry Schein Is Back on Investors’ Radar Henry Schein (HSIC) has drawn fresh attention after a stretch of mixed share performance, with modest gains over the past month and past 3 ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nasdaq-hsic/henry-schein/news/assessing-henry-scheins-valuation-as-recent-share-price-mome\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HSIC","symbol_name":"汉瑞祥","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-hsic/henry-schein/news/assessing-henry-scheins-valuation-as-recent-share-price-mome","article_id":"2610709215","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice2-main-header/1585186857496"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-hsic/henry-schein/news/assessing-henry-scheins-valuation-as-recent-share-price-mome","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2610709215","pubTimestamp":1770577753,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Why Henry Schein Is Back on Investors’ Radar\nHenry Schein (HSIC) has drawn fresh attention after a stretch of mixed share performance, with modest gains over the past month and past 3 months prompting investors to reassess the stock’s current pricing.\nSee our latest analysis for Henry Schein.\nAt a share price of US$79.72, Henry Schein has recently seen stronger short term momentum, with a 1 day share price return of 3.53% and a 90 day share price return of 9.21%, while the 1 year total...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"HSIC":"汉瑞祥","BK4585":"ETF&股票定投概念","BK4175":"保健护理产品经销商","BK4588":"碎股"},"translate_title":"随着近期股价势头引起投资者新的关注，评估亨利·沙因的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HSIC":1.5},"content_text":"AdvertisementWhy Henry Schein Is Back on Investors’ Radar Henry Schein (HSIC) has drawn fresh attention after a stretch of mixed share performance, with modest gains over the past month and past 3 months prompting investors to reassess the stock’s current pricing. See our latest analysis for Henry Schein. At a share price of US$79.72, Henry Schein has recently seen stronger short term momentum, with a 1 day share price return of 3.53% and a 90 day share price return of 9.21%, while the 1 year total shareholder return of 0.91% and 3 year total shareholder return of 7.39% decline point to a more muted longer term picture. If you are looking beyond healthcare distributors and want fresh ideas, this could be a good moment to widen your watchlist with our screener of 26 healthcare AI stocks as potential additions to research. With Henry Schein trading at US$79.72, sitting close to analyst price targets but with an intrinsic value estimate that suggests a large discount, you have to ask yourself: is there a genuine buying opportunity here, or is the market already pricing in future growth? Most Popular Narrative: 2% Overvalued Compared with the current share price of $79.72, the most followed narrative sits on a fair value estimate of $78.14, suggesting the market is only slightly ahead of that view and putting more focus on the story behind the numbers.  Henry Schein is actively pursuing operational efficiencies, including $100M+ cost savings run-rate by end of 2025 and further value creation initiatives led by KKR's Capstone, which are expected to lower operating expenses and drive net margin improvement from 2026 onward.  Read the complete narrative. Curious how a modest fair value premium rests on cost cuts, steady top line assumptions, and a lower future earnings multiple than many healthcare peers, all discounted at under 7%? The narrative lays out a detailed path tying those pieces together without assuming rapid growth. Result: Fair Value of $78.14 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, there are still clear risks, including ongoing pricing pressure in key categories and execution challenges related to cost savings and the multiyear leadership transition. Find out about the key risks to this Henry Schein narrative. Another Angle on Valuation The narrative fair value pegs Henry Schein as about 2% overvalued at $78.14, but our DCF model paints a very different picture. On that view, the shares trade at roughly a 56% discount to an estimated $179.68 per share. So which story do you find more convincing? Look into how the SWS DCF model arrives at its fair value. HSIC Discounted Cash Flow as at Feb 2026 Build Your Own Henry Schein Narrative If you look at the numbers and see a different story, or simply prefer to test your own assumptions, you can build a tailored view in just a few minutes using Do it your way. A great starting point for your Henry Schein research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision. Looking for more investment ideas? If Henry Schein has sharpened your thinking, do not stop here. Broaden your opportunity set with a few focused screens that can surface very different types of ideas.  Target long term compounding potential by reviewing companies our screener highlights as 52 high quality undervalued stocks with solid fundamentals already in place. Prioritize resilience by checking out businesses flagged in our 82 resilient stocks with low risk scores that may offer a calmer ride when markets get choppy. Get ahead of the crowd by scanning our screener containing 24 high quality undiscovered gems that the broader market might not be paying much attention to yet.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Henry Schein might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}